VDRM
Price:
$0.0078
Market Cap:
$9.62M
ViaDerma, Inc. operates as a specialty pharmaceutical company in the United States. It focuses on developing and marketing pharmaceutical products, as well as licensing its technology to companies in the pharmaceutical industry in various therapeutic areas. The company's lead product is Vitastem, a tetracycline-based topical antibiotic used for cuts, scrapes, wounds, infections, burns, acne, psoriasis, eczema, and minor injuries. It is also developing products in various fields of use, including topical antibiotics, toenail antifungal drugs, diabetic amputations, global acne, psoriasis, and eczema, as well as burns, anti-aging/wrinkle remover creams, medical cannabis, male-pattern baldness, ...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2014-10-31
Stock Exchange
PNK
Ticker
VDRM
According to ViaDerma, Inc.’s latest financial reports and current stock price. The company's current ROE is -248.00%. This represents a change of -457.04% compared to the average of 69.46% of the last 4 quarters.
The mean historical ROE of ViaDerma, Inc. over the last ten years is 35.21%. The current -248.00% ROE has changed -804.40% with respect to the historical average. Over the past ten years (40 quarters), VDRM's ROE was at its highest in in the September 2024 quarter at 222.69%. The ROE was at its lowest in in the December 2007 quarter at -246.42%.
Average
35.21%
Median
19.87%
Minimum
-32.02%
Maximum
144.46%
Discovering the peaks and valleys of ViaDerma, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 240.14%
Maximum Annual ROE = 144.46%
Minimum Annual Increase = -967.37%
Minimum Annual ROE = -32.02%
Year | ROE | Change |
---|---|---|
2023 | 3.33% | -110.39% |
2022 | -32.02% | -178.44% |
2021 | 40.83% | 106.91% |
2020 | 19.73% | -1.36% |
2019 | 20.00% | -81.85% |
2018 | 110.21% | -23.71% |
2017 | 144.46% | 240.14% |
2016 | 42.47% | -967.37% |
2015 | -4.90% | -161.48% |
2011 | 7.96% | -48.39% |
The current ROE of ViaDerma, Inc. (VDRM) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
4.04%
5-year avg
10.37%
10-year avg
35.21%
ViaDerma, Inc.’s ROE is less than U.S. Stem Cell, Inc. (15.39%), less than MMEX Resources Corporation (46.88%), greater than Decentral Life, Inc. (-12.29%), less than Herborium Group, Inc. (-1.36%), less than Visium Technologies, Inc. (59.34%),
Company | ROE | Market cap |
---|---|---|
15.39% | $64.15K | |
46.88% | $969.28K | |
-12.29% | $2.96M | |
-1.36% | $962.95K | |
59.34% | $670.59K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ViaDerma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like ViaDerma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is ViaDerma, Inc.'s ROE?
How is the ROE calculated for ViaDerma, Inc. (VDRM)?
What is the highest ROE for ViaDerma, Inc. (VDRM)?
What is the 3-year average ROE for ViaDerma, Inc. (VDRM)?
What is the 5-year average ROE for ViaDerma, Inc. (VDRM)?
How does the current ROE for ViaDerma, Inc. (VDRM) compare to its historical average?